Omada Health president sells 4,589 shares

Omada Health, Inc. President Shao Wei-Li reported an open-market sale of 4,589 shares of common stock at a weighted average price of $17.2407 per share.

Accepted by SEC EDGAR 06/16/2026 - 04:54 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Omada Health, Inc. President Shao Wei-Li reported an open-market sale of 4,589 shares of common stock at a weighted average price of $17.2407 per share. After this transaction, Wei-Li directly holds 316,238 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.

Insider Trade Summary 10b5-1

Net Seller: 4,589 shares

Net Sell 1 txn

Insider Shao Wei-Li

Role President

Sold 4,589 shs ($79K)

Share of Position Sold 1.4%

Type	Security	Shares	Price	Value
Sale	Common Stock	4,589	$17.2407	$79K

Holdings After Transaction: Common Stock — 316,238 shares (Direct)

Holdings Before and After: Common Stock, 320,827 to 316,238 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 4,589 shares Weighted average sale price: $17.2407 per share Post-transaction holdings: 316,238 shares +2 more

5 metrics

Shares sold 4,589 shares Open-market sale of common stock on June 12, 2026

Weighted average sale price $17.2407 per share Common stock sale executed in multiple trades

Post-transaction holdings 316,238 shares Common stock directly held after the sale

Price range of trades $17.10–$17.54 Range of execution prices for the reported sale

10b5-1 plan adoption date March 13, 2026 Pre-arranged trading plan governing the sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale, non-derivative

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"transaction_type: "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) President Shao Wei-Li report in this Form 4?

President Shao Wei-Li reported selling 4,589 shares of Omada Health common stock. The transaction was an open-market sale at a weighted average price of $17.2407 per share, and was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026.

At what price did Shao Wei-Li sell Omada Health (OMDA) shares?

The reported sale used a weighted average price of $17.2407 per Omada Health share. Footnotes state the trade was executed in multiple transactions within a price range from $17.10 to $17.54, with full trade details available to regulators or shareholders upon request.

How many Omada Health (OMDA) shares does Shao Wei-Li hold after this sale?

After the reported sale, Shao Wei-Li directly holds 316,238 shares of Omada Health common stock. This figure reflects the position immediately following the 4,589-share open-market transaction disclosed in the Form 4 and represents the remaining direct ownership stake reported.

Was Shao Wei-Li’s Omada Health (OMDA) share sale pre-planned?

Yes, the sale was made under a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans allow insiders to schedule trades in advance, which can reduce the significance of transaction timing as an indicator of the insider’s short-term view of the stock.

What type of transaction did Omada Health (OMDA) disclose for Shao Wei-Li?

The filing shows an open-market sale of common stock, coded as an “S” transaction. It is classified as a non-derivative transaction, meaning it involved common shares directly rather than options or other derivatives, with no associated option exercises or conversions reported.

How many Omada Health (OMDA) shares did Shao Wei-Li sell in total?

Shao Wei-Li sold 4,589 shares of Omada Health common stock in this reported transaction. The Form 4 transaction summary categorizes this as 4,589 shares sold, with no shares bought, exercised, gifted, or withheld for taxes in the same disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S(1)		4,589	D	$17.2407(2)	316,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)